Qube Research & Technologies LTD Eton Pharmaceuticals, Inc. Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 86,848 shares of ETON stock, worth $1.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,848
Previous 94,181
7.79%
Holding current value
$1.31 Million
Previous $1.24 Million
8.97%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ETON
# of Institutions
88Shares Held
14MCall Options Held
61.2KPut Options Held
33.1K-
Opaleye Management Inc. Boston, MA2.85MShares$42.9 Million10.18% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.94MShares$29.2 Million1.98% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$17.7 Million0.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$16.6 Million0.0% of portfolio
-
Cannell Capital LLC Alta, WY691KShares$10.4 Million3.17% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $380M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...